These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7657405)

  • 1. Low molecular weight immunomodulators produced by microorganisms.
    Ishizuka M; Kawatsu M; Yamashita T; Ueno M; Takeuchi T
    Int J Immunopharmacol; 1995 Feb; 17(2):133-39. PubMed ID: 7657405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delaminomycins, novel extracellular matrix receptor antagonist. IV. Structure-activity relationships of delaminomycins and derivatives.
    Ueno M; Amemiya M; Yamazaki K; Iijima M; Osono M; Someno T; Iinuma H; Hamada M; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1993 Jul; 46(7):1156-62. PubMed ID: 8360111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delaminomycins, novel nonpeptide extracellular matrix receptor antagonist and a new class of potent immunomodulator. II. Physico-chemical properties and structure elucidation of delaminomycin A.
    Ueno M; Someno T; Sawa R; Iinuma H; Naganawa H; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1993 Jun; 46(6):979-84. PubMed ID: 8393852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conagenin, a low molecular weight immunomodulator produced by Streptomyces roseosporus.
    Yamashita T; Iijima M; Nakamura H; Isshiki K; Naganawa H; Hattori S; Hamada M; Ishizuka M; Takeuchi T; Iitaka Y
    J Antibiot (Tokyo); 1991 May; 44(5):557-9. PubMed ID: 1905708
    [No Abstract]   [Full Text] [Related]  

  • 5. Delaminomycins, novel extracellular matrix receptor antagonist. III. Physico-chemical properties and structure elucidation of delaminomycins B and C.
    Ueno M; Someno T; Sawa R; Iinuma H; Naganawa H; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1993 Jun; 46(6):1020-3. PubMed ID: 8393848
    [No Abstract]   [Full Text] [Related]  

  • 6. Establishing the parabolic relationship between reactivity and activity for derivatives and analogues of the duocarmycin and CC-1065 alkylation subunits.
    Parrish JP; Hughes TV; Hwang I; Boger DL
    J Am Chem Soc; 2004 Jan; 126(1):80-1. PubMed ID: 14709069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell activation by conagenin in mice.
    Kawatsu M; Yamashita T; Osono M; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1993 Nov; 46(11):1687-91. PubMed ID: 8270490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low molecular weight immunomodulators produced by microorganisms].
    Ishizuka M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing cinnamoyl groups.
    Nagamura S; Asai A; Amishiro N; Kobayashi E; Gomi K; Saito H
    J Med Chem; 1997 Mar; 40(6):972-9. PubMed ID: 9083487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic tetramic acid derivative produced by a plant type-III polyketide synthase.
    Wakimoto T; Mori T; Morita H; Abe I
    J Am Chem Soc; 2011 Apr; 133(13):4746-9. PubMed ID: 21391603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delaminomycins, novel nonpeptide extracellular matrix receptor antagonist and a new class of potent immunomodulator. I. Taxonomy, fermentation, isolation and biological activity.
    Ueno M; Amemiya M; Iijima M; Osono M; Masuda T; Kinoshita N; Ikeda T; Iinuma H; Hamada M; Ishizuka M
    J Antibiot (Tokyo); 1993 May; 46(5):719-27. PubMed ID: 8390430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delaminomycins, novel extracellular matrix receptor antagonists. V. Biosynthesis.
    Ueno M; Yoshinaga I; Amemiya M; Someno T; Iinuma H; Ishizuaka M; Takeuchi T
    J Antibiot (Tokyo); 1993 Sep; 46(9):1390-6. PubMed ID: 8226318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of water-soluble duocarmycin B1 prodrugs.
    Asai A; Nagamura S; Kobayashi E; Gomi K; Saito H
    Bioorg Med Chem Lett; 1999 Oct; 9(20):2995-8. PubMed ID: 10571162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PM-94128, a new isocoumarin antitumor agent produced by a marine bacterium.
    Cañedo LM; Fernández Puentes JL; Pérez Baz J; Acebal C; de la Calle F; García Grávalos D; García de Quesada T
    J Antibiot (Tokyo); 1997 Feb; 50(2):175-6. PubMed ID: 9099230
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel antibiotic CJ-17,572 from a fungus, Pezicula sp.
    Sugie Y; Dekker KA; Inagaki T; Kim YJ; Sakakibara T; Sakemi S; Sugiura A; Brennan L; Duignan J; Sutcliffe JA; Kojima Y
    J Antibiot (Tokyo); 2002 Jan; 55(1):19-24. PubMed ID: 11918060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new isocoumarin antibiotic, Y-05460M-A.
    Sato T; Nagai K; Suzuki K; Morioka M; Saito T; Nohara C; Susaki K; Takebayashi Y
    J Antibiot (Tokyo); 1992 Dec; 45(12):1949-52. PubMed ID: 1490888
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of conagenin in tumor bearing mice. Antitumor activity, generation of effector cells and cytokine production.
    Kawatsu M; Yamashita T; Osono M; Masuda T; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1993 Nov; 46(11):1692-8. PubMed ID: 8270491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duocarmycins, potent antitumor antibiotics produced by Streptomyces sp. structures and chemistry.
    Yasuzawa T; Muroi K; Ichimura M; Takahashi I; Ogawa T; Takahashi K; Sano H; Saitoh Y
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):378-91. PubMed ID: 7774022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and structure elucidation of vicenistatin M, and importance of the vicenisamine aminosugar for exerting cytotoxicity of vicenistatin.
    Matsushima Y; Nakayama T; Fujita M; Bhandari R; Eguchi T; Shindo K; Kakinuma K
    J Antibiot (Tokyo); 2001 Mar; 54(3):211-9. PubMed ID: 11372778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.